Bill Text: TX SB2176 | 2017-2018 | 85th Legislature | Comm Sub
Bill Title: Relating to the placement of certain substances in Penalty Groups 1 and 3 of the Texas Controlled Substances Act for the purposes of prosecution of criminal offenses involving those substances.
Spectrum: Partisan Bill (Republican 1-0)
Status: (Introduced - Dead) 2017-04-18 - Committee report printed and distributed [SB2176 Detail]
Download: Texas-2017-SB2176-Comm_Sub.html
By: Hughes | S.B. No. 2176 | |
(In the Senate - Filed March 10, 2017; March 29, 2017, read | ||
first time and referred to Committee on Criminal Justice; | ||
April 18, 2017, reported adversely, with favorable Committee | ||
Substitute by the following vote: Yeas 7, Nays 0; April 18, 2017, | ||
sent to printer.) | ||
COMMITTEE SUBSTITUTE FOR S.B. No. 2176 | By: Whitmire |
|
||
|
||
relating to the placement of certain substances in Penalty Groups 1 | ||
and 3 of the Texas Controlled Substances Act for the purposes of | ||
prosecution of criminal offenses involving those substances. | ||
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | ||
SECTION 1. Section 481.102, Health and Safety Code, is | ||
amended to read as follows: | ||
Sec. 481.102. PENALTY GROUP 1. Penalty Group 1 consists of: | ||
(1) the following opiates, including their isomers, | ||
esters, ethers, salts, and salts of isomers, esters, and ethers, | ||
unless specifically excepted, if the existence of these isomers, | ||
esters, ethers, and salts is possible within the specific chemical | ||
designation: | ||
Alfentanil; | ||
Allylprodine; | ||
Alphacetylmethadol; | ||
Benzethidine; | ||
Betaprodine; | ||
Clonitazene; | ||
Diampromide; | ||
Diethylthiambutene; | ||
Difenoxin not listed in Penalty Group 3 or 4; | ||
Dimenoxadol; | ||
Dimethylthiambutene; | ||
Dioxaphetyl butyrate; | ||
Dipipanone; | ||
Ethylmethylthiambutene; | ||
Etonitazene; | ||
Etoxeridine; | ||
Furethidine; | ||
Hydroxypethidine; | ||
Ketobemidone; | ||
Levophenacylmorphan; | ||
Meprodine; | ||
Methadol; | ||
Moramide; | ||
Morpheridine; | ||
Noracymethadol; | ||
Norlevorphanol; | ||
Normethadone; | ||
Norpipanone; | ||
Phenadoxone; | ||
Phenampromide; | ||
Phenomorphan; | ||
Phenoperidine; | ||
Piritramide; | ||
Proheptazine; | ||
Properidine; | ||
Propiram; | ||
Sufentanil; | ||
Tilidine; and | ||
Trimeperidine; | ||
(2) the following opium derivatives, their salts, | ||
isomers, and salts of isomers, unless specifically excepted, if the | ||
existence of these salts, isomers, and salts of isomers is possible | ||
within the specific chemical designation: | ||
Acetorphine; | ||
Acetyldihydrocodeine; | ||
Benzylmorphine; | ||
Codeine methylbromide; | ||
Codeine-N-Oxide; | ||
Cyprenorphine; | ||
Desomorphine; | ||
Dihydromorphine; | ||
Drotebanol; | ||
Etorphine, except hydrochloride salt; | ||
Heroin; | ||
Hydromorphinol; | ||
Methyldesorphine; | ||
Methyldihydromorphine; | ||
Monoacetylmorphine; | ||
Morphine methylbromide; | ||
Morphine methylsulfonate; | ||
Morphine-N-Oxide; | ||
Myrophine; | ||
Nicocodeine; | ||
Nicomorphine; | ||
Normorphine; | ||
Pholcodine; and | ||
Thebacon; | ||
(3) the following substances, however produced, | ||
except those narcotic drugs listed in another group: | ||
(A) Opium and opiate not listed in Penalty Group | ||
3 or 4, and a salt, compound, derivative, or preparation of opium or | ||
opiate, other than thebaine derived butorphanol, nalmefene and its | ||
salts, naloxone and its salts, and naltrexone and its salts, but | ||
including: | ||
Codeine not listed in Penalty Group 3 or 4; | ||
Dihydroetorphine; | ||
Ethylmorphine not listed in Penalty Group 3 | ||
or 4; | ||
Granulated opium; | ||
Hydrocodone not listed in Penalty Group 3; | ||
Hydromorphone; | ||
Metopon; | ||
Morphine not listed in Penalty Group 3; | ||
Opium extracts; | ||
Opium fluid extracts; | ||
Oripavine; | ||
Oxycodone; | ||
Oxymorphone; | ||
Powdered opium; | ||
Raw opium; | ||
Thebaine; and | ||
Tincture of opium; | ||
(B) a salt, compound, isomer, derivative, or | ||
preparation of a substance that is chemically equivalent or | ||
identical to a substance described by Paragraph (A), other than the | ||
isoquinoline alkaloids of opium; | ||
(C) Opium poppy and poppy straw; | ||
(D) Cocaine, including: | ||
(i) its salts, its optical, position, and | ||
geometric isomers, and the salts of those isomers; | ||
(ii) coca leaves and a salt, compound, | ||
derivative, or preparation of coca leaves; and | ||
(iii) a salt, compound, derivative, or | ||
preparation of a salt, compound, or derivative that is chemically | ||
equivalent or identical to a substance described by Subparagraph | ||
(i) or (ii), other than decocainized coca leaves or extractions of | ||
coca leaves that do not contain cocaine or ecgonine; and | ||
(E) concentrate of poppy straw, meaning the crude | ||
extract of poppy straw in liquid, solid, or powder form that | ||
contains the phenanthrine alkaloids of the opium poppy; | ||
(4) the following opiates, including their isomers, | ||
esters, ethers, salts, and salts of isomers, if the existence of | ||
these isomers, esters, ethers, and salts is possible within the | ||
specific chemical designation: | ||
Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2- | ||
phenethyl)-4-piperidinyl]-N-phenylacetamide); | ||
Alpha-methylthiofentanyl (N-[1-methyl-2-(2- | ||
thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide); | ||
Alphaprodine; | ||
Anileridine; | ||
Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2- | ||
phenethyl)-4-piperidinyl] -N-phenylpropanamide); | ||
Beta-hydroxy-3-methylfentanyl; | ||
Bezitramide; | ||
Carfentanil; | ||
Dihydrocodeine not listed in Penalty Group 3 or 4; | ||
Diphenoxylate not listed in Penalty Group 3 or 4; | ||
Fentanyl or alpha-methylfentanyl, or any other | ||
derivative of Fentanyl; | ||
Isomethadone; | ||
Levomethorphan; | ||
Levorphanol; | ||
Metazocine; | ||
Methadone; | ||
Methadone-Intermediate, 4-cyano-2-dimethylamino- | ||
4, 4-diphenyl butane; | ||
3-methylfentanyl(N-[3-methyl-1-(2-phenylethyl)- | ||
4-piperidyl]-N-phenylpropanamide); | ||
3-methylthiofentanyl(N-[3-methyl-1-(2-thienyl) | ||
ethyl-4-piperidinyl]-N-phenylpropanamide); | ||
Moramide-Intermediate, 2-methyl-3-morpholino-1, | ||
1-diphenyl-propane-carboxylic acid; | ||
Para-fluorofentanyl(N-(4-fluorophenyl)-N-1-(2- | ||
phenylethyl)-4-piperidinylpropanamide); | ||
PEPAP (1-(2-phenethyl)-4-phenyl-4- | ||
acetoxypiperidine); | ||
Pethidine (Meperidine); | ||
Pethidine-Intermediate-A, 4-cyano-1-methyl-4- | ||
phenylpiperidine; | ||
Pethidine-Intermediate-B, ethyl-4- | ||
phenylpiperidine-4 carboxylate; | ||
Pethidine-Intermediate-C, 1-methyl-4- | ||
phenylpiperidine-4-carboxylic acid; | ||
Phenazocine; | ||
Piminodine; | ||
Racemethorphan; | ||
Racemorphan; | ||
Remifentanil; and | ||
Thiofentanyl(N-phenyl-N-[1-(2-thienyl)ethyl-4-pi | ||
peridinyl]-propanamide); | ||
(5) Flunitrazepam (trade or other name: Rohypnol); | ||
(6) Methamphetamine, including its salts, optical | ||
isomers, and salts of optical isomers; | ||
(7) Phenylacetone and methylamine, if possessed | ||
together with intent to manufacture methamphetamine; | ||
(8) Phencyclidine, including its salts; | ||
(9) Gamma hydroxybutyric acid (some trade or other | ||
names: gamma hydroxybutyrate, GHB), including its salts; [ |
||
(10) Ketamine; | ||
(11) Phenazepam; | ||
(12) U-47700; and | ||
(13) AH-7921. | ||
SECTION 2. Section 481.104(a), Health and Safety Code, is | ||
amended to read as follows: | ||
(a) Penalty Group 3 consists of: | ||
(1) a material, compound, mixture, or preparation that | ||
contains any quantity of the following substances having a | ||
potential for abuse associated with a stimulant effect on the | ||
central nervous system: | ||
Methylphenidate and its salts; and | ||
Phenmetrazine and its salts; | ||
(2) a material, compound, mixture, or preparation that | ||
contains any quantity of the following substances having a | ||
potential for abuse associated with a depressant effect on the | ||
central nervous system: | ||
a substance that contains any quantity of a | ||
derivative of barbituric acid, or any salt of a derivative of | ||
barbituric acid not otherwise described by this subsection; | ||
a compound, mixture, or preparation containing | ||
amobarbital, secobarbital, pentobarbital, or any salt of any of | ||
these, and one or more active medicinal ingredients that are not | ||
listed in any penalty group; | ||
a suppository dosage form containing amobarbital, | ||
secobarbital, pentobarbital, or any salt of any of these drugs, and | ||
approved by the United States Food and Drug Administration for | ||
marketing only as a suppository; | ||
Alprazolam; | ||
Amobarbital; | ||
Bromazepam; | ||
Camazepam; | ||
Carisoprodol; | ||
Chlordiazepoxide; | ||
Chlorhexadol; | ||
Clobazam; | ||
Clonazepam; | ||
Clorazepate; | ||
Clotiazepam; | ||
Cloxazolam; | ||
Delorazepam; | ||
Diazepam; | ||
Estazolam; | ||
Ethyl loflazepate; | ||
Etizolam; | ||
Fludiazepam; | ||
Flurazepam; | ||
Glutethimide; | ||
Halazepam; | ||
Haloxzolam; | ||
Ketazolam; | ||
Loprazolam; | ||
Lorazepam; | ||
Lormetazepam; | ||
Lysergic acid, including its salts, isomers, and | ||
salts of isomers; | ||
Lysergic acid amide, including its salts, | ||
isomers, and salts of isomers; | ||
Mebutamate; | ||
Medazepam; | ||
Methyprylon; | ||
Midazolam; | ||
Nimetazepam; | ||
Nitrazepam; | ||
Nordiazepam; | ||
Oxazepam; | ||
Oxazolam; | ||
Pentazocine, its salts, derivatives, or compounds | ||
or mixtures thereof; | ||
Pentobarbital; | ||
Pinazepam; | ||
Prazepam; | ||
Quazepam; | ||
Secobarbital; | ||
Sulfondiethylmethane; | ||
Sulfonethylmethane; | ||
Sulfonmethane; | ||
Temazepam; | ||
Tetrazepam; | ||
Tiletamine and zolazepam in combination, and its | ||
salts. (some trade or other names for a tiletamine-zolazepam | ||
combination product: Telazol, for tiletamine: 2-(ethylamino)- | ||
2-(2-thienyl)-cyclohexanone, and for zolazepam: 4-(2- | ||
fluorophenyl)-6, 8-dihydro-1,3,8,-trimethylpyrazolo-[3,4- | ||
e](1,4)-d diazepin-7(1H)-one, flupyrazapon); | ||
Tramadol; | ||
Triazolam; | ||
Zaleplon; | ||
Zolpidem; and | ||
Zopiclone; | ||
(3) Nalorphine; | ||
(4) a material, compound, mixture, or preparation | ||
containing limited quantities of the following narcotic drugs, or | ||
any of their salts: | ||
not more than 1.8 grams of codeine, or any of its | ||
salts, per 100 milliliters or not more than 90 milligrams per dosage | ||
unit, with an equal or greater quantity of an isoquinoline alkaloid | ||
of opium; | ||
not more than 1.8 grams of codeine, or any of its | ||
salts, per 100 milliliters or not more than 90 milligrams per dosage | ||
unit, with one or more active, nonnarcotic ingredients in | ||
recognized therapeutic amounts; | ||
not more than 300 milligrams of dihydrocodeinone | ||
(hydrocodone), or any of its salts, per 100 milliliters or not more | ||
than 15 milligrams per dosage unit, with a fourfold or greater | ||
quantity of an isoquinoline alkaloid of opium; | ||
not more than 300 milligrams of dihydrocodeinone | ||
(hydrocodone), or any of its salts, per 100 milliliters or not more | ||
than 15 milligrams per dosage unit, with one or more active, | ||
nonnarcotic ingredients in recognized therapeutic amounts; | ||
not more than 1.8 grams of dihydrocodeine, or any | ||
of its salts, per 100 milliliters or not more than 90 milligrams per | ||
dosage unit, with one or more active, nonnarcotic ingredients in | ||
recognized therapeutic amounts; | ||
not more than 300 milligrams of ethylmorphine, or | ||
any of its salts, per 100 milliliters or not more than 15 milligrams | ||
per dosage unit, with one or more active, nonnarcotic ingredients | ||
in recognized therapeutic amounts; | ||
not more than 500 milligrams of opium per 100 | ||
milliliters or per 100 grams, or not more than 25 milligrams per | ||
dosage unit, with one or more active, nonnarcotic ingredients in | ||
recognized therapeutic amounts; | ||
not more than 50 milligrams of morphine, or any of | ||
its salts, per 100 milliliters or per 100 grams with one or more | ||
active, nonnarcotic ingredients in recognized therapeutic amounts; | ||
and | ||
not more than 1 milligram of difenoxin and not | ||
less than 25 micrograms of atropine sulfate per dosage unit; | ||
(5) a material, compound, mixture, or preparation that | ||
contains any quantity of the following substances: | ||
Barbital; | ||
Chloral betaine; | ||
Chloral hydrate; | ||
Ethchlorvynol; | ||
Ethinamate; | ||
Meprobamate; | ||
Methohexital; | ||
Methylphenobarbital (Mephobarbital); | ||
Paraldehyde; | ||
Petrichloral; and | ||
Phenobarbital; | ||
(6) Peyote, unless unharvested and growing in its | ||
natural state, meaning all parts of the plant classified | ||
botanically as Lophophora, whether growing or not, the seeds of the | ||
plant, an extract from a part of the plant, and every compound, | ||
manufacture, salt, derivative, mixture, or preparation of the | ||
plant, its seeds, or extracts; | ||
(7) unless listed in another penalty group, a | ||
material, compound, mixture, or preparation that contains any | ||
quantity of the following substances having a stimulant effect on | ||
the central nervous system, including the substance's salts, | ||
optical, position, or geometric isomers, and salts of the | ||
substance's isomers, if the existence of the salts, isomers, and | ||
salts of isomers is possible within the specific chemical | ||
designation: | ||
Benzphetamine; | ||
Cathine [(+)-norpseudoephedrine]; | ||
Chlorphentermine; | ||
Clortermine; | ||
Diethylpropion; | ||
Fencamfamin; | ||
Fenfluramine; | ||
Fenproporex; | ||
Mazindol; | ||
Mefenorex; | ||
Modafinil; | ||
Pemoline (including organometallic complexes and | ||
their chelates); | ||
Phendimetrazine; | ||
Phentermine; | ||
Pipradrol; | ||
Sibutramine; and | ||
SPA [(-)-1-dimethylamino-1,2-diphenylethane]; | ||
(8) unless specifically excepted or unless listed in | ||
another penalty group, a material, compound, mixture, or | ||
preparation that contains any quantity of the following substance, | ||
including its salts: | ||
Dextropropoxyphene (Alpha-(+)-4-dimethylamino- | ||
1,2-diphenyl-3-methyl-2-propionoxybutane); | ||
(9) an anabolic steroid, including any drug or | ||
hormonal substance, or any substance that is chemically or | ||
pharmacologically related to testosterone, other than an estrogen, | ||
progestin, dehydroepiandrosterone, or corticosteroid, and promotes | ||
muscle growth, including the following drugs and substances and any | ||
salt, ester, or ether of the following drugs and substances: | ||
Androstanediol; | ||
Androstanedione; | ||
Androstenediol; | ||
Androstenedione; | ||
Bolasterone; | ||
Boldenone; | ||
Calusterone; | ||
Clostebol; | ||
Dehydrochlormethyltestosterone; | ||
Delta-1-dihydrotestosterone; | ||
Dihydrotestosterone (4-dihydrotestosterone); | ||
Drostanolone; | ||
Ethylestrenol; | ||
Fluoxymesterone; | ||
Formebulone; | ||
Furazabol; | ||
13beta-ethyl-17beta-hydroxygon-4-en-3-one; | ||
4-hydroxytestosterone; | ||
4-hydroxy-19-nortestosterone; | ||
Mestanolone; | ||
Mesterolone; | ||
Methandienone; | ||
Methandriol; | ||
Methenolone; | ||
17alpha-methyl-3beta, 17 beta-dihydroxy-5alpha- | ||
androstane; | ||
17alpha-methyl-3alpha, 17 beta-dihydroxy-5alpha- | ||
androstane; | ||
17alpha-methyl-3beta, 17beta-dihydroxyandrost-4- | ||
ene; | ||
17alpha-methyl-4-hydroxynandrolone; | ||
Methyldienolone; | ||
Methyltestosterone; | ||
Methyltrienolone; | ||
17alpha-methyl-delta-1-dihydrotestosterone; | ||
Mibolerone; | ||
Nandrolone; | ||
Norandrostenediol; | ||
Norandrostenedione; | ||
Norbolethone; | ||
Norclostebol; | ||
Norethandrolone; | ||
Normethandrolone; | ||
Oxandrolone; | ||
Oxymesterone; | ||
Oxymetholone; | ||
Stanozolol; | ||
Stenbolone; | ||
Testolactone; | ||
Testosterone; | ||
Tetrahydrogestrinone; and | ||
Trenbolone; and | ||
(10) Salvia divinorum, unless unharvested and growing | ||
in its natural state, meaning all parts of that plant, whether | ||
growing or not, the seeds of that plant, an extract from a part of | ||
that plant, and every compound, manufacture, salt, derivative, | ||
mixture, or preparation of that plant, its seeds, or extracts, | ||
including Salvinorin A. | ||
SECTION 3. The change in law made by this Act applies only | ||
to an offense committed on or after the effective date of this Act. | ||
An offense committed before the effective date of this Act is | ||
governed by the law in effect on the date the offense was committed, | ||
and the former law is continued in effect for that purpose. For | ||
purposes of this section, an offense was committed before the | ||
effective date of this Act if any element of the offense occurred | ||
before that date. | ||
SECTION 4. This Act takes effect September 1, 2017. | ||
* * * * * |